The present study was conducted to determine whether estrogen regulates the P-450 cholesterol side-chain cleavage (P-450scc) enzyme component of the progesterone biosynthetic pathway in the placenta during the second half of baboon pregnancy. Placental estrogen formation was suppressed by removing the fetus, i.e. fetectomy, and thus fetal adrenal C 19 -steroid estrogen precursors, on day 100 of baboon gestation (term ϭ 184 days). P-450scc activity and messenger ribonucleic acid (mRNA) levels were then determined in placentas obtained on day 160 after fetectomy alone and after fetectomy and sc administration of the estrogen precursor androstenedione or estradiol benzoate.
T HE MITOCHONDRIAL cytochrome P-450 cholesterol side-chain cleavage (P-450scc) enzyme system catalyzes the conversion of cholesterol to pregnenolone, and this represents a rate-limiting step in steroid hormone biosynthesis in several tissues (Ref. 1, for review). The P-450scc enzyme system is comprised of cytochrome P-450, an NADPH-dependent flavoprotein dehydrogenase, and ironsulfur protein adrenodoxin. Although the stimulatory effects of cAMP and transcriptional regulation of the P-450scc gene have been studied extensively in vitro in the human placenta by Miller et al. (2, 3) and Strauss et al. (4, 5) , relatively little is known about the regulation of P-450scc within the placenta in vivo during primate pregnancy (6, 7) . In human pregnancy, placental P-450scc activity is 2-to 3-fold greater at term than earlier in gestation (8) , and in baboons there is a progressive developmental increase in expression of P-450scc messenger ribonucleic acid (mRNA) levels within placental syncytiotrophoblasts during advancing stages of pregnancy when estrogen levels become elevated (9) . Moreover, the administration of an antiestrogen to baboons in the second half of pregnancy decreased placental P-450scc activity (10) . Therefore, we have proposed that estrogen regulates the P-450scc enzymatic conversion of cholesterol to pregnenolone, and thus progesterone formation within placental syncytiotrophoblasts, during primate pregnancy.
Our present studies are focused on elucidating the subcellular mechanisms by which estrogen regulates P-450scc activity and whether the developmental increase in placental P-450scc mRNA is dependent upon estrogen. We have shown previously that removal of the fetus, but not the placenta, i.e. fetectomy, at midgestation in baboons (11) eliminates fetal adrenal C 19 -steroid estrogen precursors and results in a decline in placental estrogen formation. However, after fetectomy the placenta remains in situ, viable, and functional with respect to the potential for formation of estrogen from aromatizable C 19 -steroids (12) and syncytiotrophoblast-specific proteins (13) . Thus, in the present study, we determined the mRNA levels for and activity of the P-450scc within the placenta after fetectomy and androstenedione or estradiol administration to ascertain the role of estrogen on placental P-450scc expression in the second half of baboon pregnancy.
Materials and Methods Animals
Female baboons (Papio anubis), weighing 13-18 kg, were housed individually in aluminum-stainless steel cages and paired with males for 5 days at the anticipated time of ovulation, as estimated by menstrual cycle history and turgescence of external sex skin. Blood samples (5 ml) were obtained from a saphenous vein of pregnant baboons at 1-to 2-day intervals between days 100 and 160 of gestation (term is 184 days).
Baboons either served as untreated intact controls or underwent fetectomy using halothane (1.5%): nitrous oxide (0.5 1/min): oxygen (2.0 1/min) anesthesia on day 100 of gestation as described previously (11) . Fetectomized animals either were not further treated, received 50 mg pellets of the estrogen precursor androstenedione (Innovative Research, Toledo, OH) implanted sc in the mother in increasing numbers between days 100 and 155 of gestation (one on day 100, two on day 110, and three each on days 120, 130, 140, 150, and 155), or were injected sc with estradiol benzoate in 0.5 cc sesame oil in increasing amounts of 0.5-2.5 mg per day between days 101-160 of gestation. Intact animals also received androstenedione implants, as described above, on days 100 -155 to serve as steroid-injected controls. On day 160 of gestation, baboons were anesthetized with halothane, a laparotomy and hysterotomy performed, and placentas were removed. Placentas were rinsed in icecold 0.9% saline and cleared of membranes and decidua, and villous tissue was immediately processed for the determination of P-450scc activity or frozen in liquid nitrogen for the analysis of P-450scc mRNA levels. Because the baboons used for the determination of placental P-450scc activity were studied before the P-450scc mRNA assay or RNA collections were implemented in our laboratory, an additional set of intact and fetectomized baboons was used for P-450scc mRNA analysis. Moreover, because similar P-450scc activity results were obtained with androstenedione and estradiol treatment, only one of these regimens, i.e. androstenedione administration, was used for the study of P-450scc mRNA levels. Animals were cared for and used strictly in accordance with USDA regulations and the NIH Guide for the Care and Use of Laboratory Animals (Publication No 85-23, 1985) . The experimental protocol was approved by the Institutional Animal Care and Use Committee of the University of Maryland School of Medicine.
Immunocytochemistry of pregnancy-specific-␤ 1 -glycoprotein (SP 1 )
Placental villous sections were stained with hematoxylin and eosin or affixed to coverslips for immunocytochemical analysis of SP 1 , as detailed previously (14) . The primary antiserum against human SP 1 (1:1200, Dako, Santa Barbara, CA) was visualized using goat antirabbit antisera, rabbit peroxidase, antiperoxidase, and hydrogen peroxidase: 3,3Ј-diaminobenzidine-tetrahydrochloride:Tris solution.
Competitive RT-PCR
A sensitive competitive RT-PCR assay was established to quantify mRNA in whole villous tissue of the present study and for purposes of future studies of low RNA levels in purified trophoblast cell fractions.
Preparation of RNA. Sections of whole villous tissue were homogenized in 4 m guanidine isothiocyanate extracted with chloroform: isoamylalcohol, and total RNA obtained via cesium chloride gradient centrifugation. Construction of internal standard RNA. P-450scc-competitive reference standard (CRS) was prepared adapting the method of Riedy et al. (17) , using RT-PCR to generate the cDNA template, followed by transcription with T7 polymerase. Total RNA (5 g) from baboon placenta was reversed transcribed at 37 C for 60 min in a reaction mixture (20 l 2 , and 10 pmol primer 1. After 60 min, the RT mixture was cooled to 4 C and then added to a PCR reaction mixture (80 l) containing 8 mm Tris-HCl (pH 8.3), 0.9 mm MgCl 2 , 40 mm KCl, 2.5 U cloned Thermus aquaticus DNA polymerase (Amplitaq, PerkinElmer/Cetus, Norwalk, CT), and 10 pmol primer 2. PCR was performed in a programmable thermal cycler (MJ Research, Cambridge, MA) and the sample amplified in 25 sequential cycles at 94 C for 1 min, 60 C for 1 min, and 72 C for 2 min. After the last cycle, the sample was incubated for an additional 5 min at 72 C. A portion of the PCR reaction mixture was fractionated by electrophoresis in a 2% agarose gel and visualized in ethidium bromide. The amplified product (320 bp) contains sequences for the T7 polymerase and has an 80-bp deletion as compared with the target (wild type) mRNA strand. The PCR product was gel purified using the QIAEX DNA gel extraction kit (Qiagen Inc., Chatsworth, CA). P-450scc-CRS was synthesized from 200 ng cDNA template using the MEGAscript T7 in vitro transcription kit (Ambion Inc., Austin, TX).
Competitive RT-PCR.
A constant amount of total RNA (2.5 g) from villous tissue was added to the RT mixture containing 2-fold serial dilutions of the P-450scc-CRS (500 -125 attomoles) in the presence of 10 pmol of primer 3. Upon completion of the RT, 10 pmol primer 4 was added for the PCR reaction. Two negative controls, in which either RNA or RT were omitted from the reaction, were also performed. The PCR products were fractionated by electrophoresis in a 2% agarose gel, stained in ethidium bromide, visualized with a UV transilluminator, and photographed using type 665 positive/negative film (Polaroid Corp., Cambridge, MA).
Quantification of P-450scc. Photographs (negative image), representing amplified products, were analyzed by autoradiographic scanning using a model 620 Video Densitometer (Bio-Rad, Richmond, CA). The intensity of the amplified products was represented as the relative area under each sample band. A correction factor (18) was used to correct for the size difference between P-450scc-CRS cDNA and the P-450scc target cDNA: corrected relative area ϭ relative area ϫ P-450scc target bp length/P-450scc-CRS bp length. The logarithm (log) of the ratio of P-450scc-CRS area to P-450scc target area was plotted as a function of the concentration of P-450scc-CRS added to each PCR reaction. The concentration of P-450scc mRNA was determined where the ratio of P-450scc-CRS and P-450scc target areas was equal to 1 (i.e. equivalence point).
Validation of assay. To ensure that the P-450scc-CRS and P-450scc target template amplified with similar efficiencies, their amplification kinetics were compared as described (19) . Total RNA (2.5 g) from whole villous tissue and 275 attomoles of P-450scc-CRS were reversed transcribed and amplified by PCR. The log of the P-450scc-CRS and P-450scc target areas was plotted as a function of the cycle number ( Fig. 1 ). Amplification proceeded with the same efficiency for both templates because the resultant PCR products accumulated in a parallel manner throughout both the exponential and nonexponential phases.
Placental mitochondrial P-450scc activity
The procedures of Toaff and co-workers (20) and Holt and Schreiber (21) , as modified by Babischkin et al. (10) in our laboratory, were used to determine placental P-450scc activity in a mitochondria-rich pellet of homogenized villous tissue obtained by sedimentation at 5000 ϫ g for 10 min at 4 C. Mitochondria (80 g protein/ml) was incubated in 0.2 m sucrose, 25 mm Tris-HCl buffer containing 10 mm isocitrate and 1 mm NADPH. After removal of mitochondrial aliquots containing the complete assay mixture for estimation of pregnenolone and progesterone concentrations at time zero, reactions were initiated by incubating mi-tochondria in triplicate in a Dubnoff metabolic shaker under atmospheric conditions at 70 cycles/min and 37 C for 30 min. Reactions were terminated by the addition of 0.3 N NaOH, and samples stored at Ϫ20 C until the steroid products, i.e. pregnenolone and progesterone, were analyzed by RIA. Preliminary experiments confirmed that pregnenolone and progesterone formation increased linearly throughout a 4-h period in mitochondria of control and estrogen-depleted baboons incubated in the presence or absence of 62 m soluble substrate 25-hydroxycholesterol (Steraloids, Wilton, NH). For this reason, and because endogenous cholesterol content in baboon placental mitochondria seems extensive and similar in untreated and estrogen-deprived baboons (10), the P-450scc enzyme assay was conducted in the absence of exogenous substrate.
Cyanoketone, an inhibitor of ⌬ 5 -3␤-hydroxysteroid dehydrogenase, was not used in the assay to prevent the conversion of pregnenolone to progesterone because this synthetic steroid binds to oxidized placental cytochrome P-450 and inhibits activity. Rather, P-450scc activity was expressed as the net amount of pregnenolone plus progesterone formed, as determined by subtracting the zero-time steroid values from those obtained after the incubation period.
RIA of steroids
One milliliter of the mitochondrial assay incubate was extracted two times with 5 ml of diethyl ether, and pregnenolone and progesterone content were determined by 3 H RIA, basically as previously described in our laboratory (22) . Prior comparison of results for pregnenolone and progesterone assay with and without Sephadex LH-20 affinity chromatography of mitochondrial incubates indicated that purification of aliquots before RIA was unnecessary.
Serum estradiol was determined by RIA using solid-phase 125 I-RIA (Coat-A-Count, Diagnostic Products Corp., Los Angeles, CA).
Statistical analysis
The data were analyzed by ANOVA with post hoc comparison of the means by Newman-Keuls multiple comparison test.
Results

Serum estradiol
Peripheral serum estradiol concentrations in untreated baboons increased gradually during the second half of gestation and approximated 2 ng/ml immediately before cesarean section on day 160 (Fig. 2) . The overall mean (Ϯse) serum estradiol level in untreated control baboons on days 101-160 of gestation was 1.22 Ϯ 0.05 ng/ml (Fig. 3) . Fetectomy was associated with a marked decrease in serum estradiol concentration (Fig. 2) to a mean between days 101-160 of gestation of 0.30 Ϯ 0.03 ng/ml, or 24% of that (P Ͻ 0.01) in untreated controls at the same interval (Fig. 3) . Administration of androstenedione after fetectomy partially restored serum estradiol concentrations to a mean on days 101-160 of 0.69 Ϯ 0.03 ng/ml, or 57% of normal (P Ͻ 0.01, Figs. 2 and  3 ). The administration of estradiol after fetectomy resulted in a mean (Ϯse) serum estradiol concentration of 2.32 Ϯ 0.11 ng/ml, a value 90% greater (P Ͻ 0.001) than in untreated, intact animals. Treatment of intact baboons with andro- stenedione resulted in a mean serum estradiol concentration of 2.82 Ϯ 0.20 ng/ml on days 101-160, a value 2-fold greater (P Ͻ 0.01) than in untreated controls (data not shown in figure) .
Placental histology and immunocytochemistry of SP 1
Placental weight after fetectomy was 52% lower (P Ͻ 0.001) than that of intact untreated control baboons (Table 1) . Placental weights after fetectomy and administration of androstenedione or estradiol were 54% and 55% (P Ͻ 0.01), respectively, also lower than in controls at term, and only approximately 18% larger than that previously determined in untreated baboons at midgestation (85 Ϯ 7).
As we have previously reported (23), syncytiotrophoblasts predominated, seemed normal morphologically, and formed a continuous surface covering of villi in placental tissue obtained near term from both intact baboons and animals that had undergone fetectomy. Although the fetal surface of the placenta became devascularized after fetectomy, the trophoblast cellular layer, as illustrated by hematoxylin and eosin histology (Fig. 4B ), seemed to remain intact and very similar in appearance to that in the untreated controls (Fig. 4A) . Moreover, syncytiotrophoblasts of intact baboons (Fig. 4C ) and animals that had undergone fetectomy (Fig. 4D ) exhibited an equally extensive level of reactivity with antisera to syncytiotrophoblast-specific SP 1 . Consequently, on the basis of their capacity to aromatize androstenedione to estradiol and express SP 1 , syncytiotrophoblasts of fetectomized baboons were functional.
Placental P-450scc activity
The assay of mitochondrial P-450scc activity was validated in the baboon placenta in a prior study in our laboratory (10) , in which we demonstrated by electron microscopy that the cellular fraction analyzed was mitochondria enriched, and mitochondrial membranes remained intact using the preparative conditions outlined above. Moreover, enzyme activity was directly proportional to time of incubation and mitochondrial protein concentration, and formation of pregnenolone from intramitochondrial cholesterol was markedly suppressed in the presence of inhibitor aminoglutethimide.
Mean (Ϯse) specific activity of placental P-450scc in mitochondria of untreated baboons was 281.1 Ϯ 15.0 pmol pregnenolone plus progesterone formed per mg protein. Fetectomy resulted in a 52% decrease (P Ͻ 0.001) in placental P-450scc activity (133.7 Ϯ 22.1, Fig. 5 ). The administration of androstenedione after fetectomy increased P-450scc to a level (226.0 Ϯ 35.5) that was greater (P Ͻ 0.05) than with fetectomy alone and 80% of, and not significantly different from, that observed in the intact controls. Mean P-450scc activity in baboons treated with estradiol benzoate after fetectomy was 337.0 Ϯ 39.9, a value greater (P Ͻ 0.001) than with fetectomy alone and similar to that of the untreated intact controls. Androstenedione treatment of intact baboons resulted in P-450scc levels (212.8 Ϯ 58.9) that were not significantly different from normal.
Placental P-450scc mRNA levels by competitive RT-PCR
A representative quantitative analysis of P-450scc mRNA levels by competitive RT-PCR in baboon placental villous tissue is shown in Fig. 6 . The expected 370-bp P-450scc PCR target product generated from villous total RNA and 290 bp-PCR product generated from P-450scc-CRS were expressed (Fig. 6A ). In contrast, there was no PCR product formed when RNA or RT were omitted from the reaction (not shown). The slopes of the log of the CRS to target areas plotted as a function of CRS added were similar for trophoblast RNA obtained from intact (slope ϭ 1.22) and fetectomized (slope ϭ 1.08) baboons (Fig. 6B) , indicating no difference in amplification efficiency. However, analysis of the equivalence points from each plot indicated that placental P-450scc mRNA levels were different in intact and fetectomized baboons. The P-450scc mRNA level in villous tissue of untreated intact baboons in late gestation was 110.9 Ϯ 5.9 attomoles/g RNA (Fig. 7) . Fetectomy resulted in a P-450scc mRNA level (69.2 Ϯ 7.0 attomoles/g RNA) that was 38% lower (P Ͻ 0.01) than in the intact controls. Administration of androstenedione after fetectomy restored P-450scc mRNA to a level (96.4 Ϯ 9.1) that was greater (P Ͻ 0.05) than with fetectomy alone and similar to that observed in the untreated controls.
Discussion
The results of the present study show that there was a close association between the levels of estrogen and the expression of the mRNAs for, and specific activity of, placental P-450scc in baboons. These findings are consistent with prior observations in humans, where placental P-450scc activity was highest at term when estrogen levels are maximal (8) , and in baboons, where the mRNA levels for P-450scc within isolated syncytiotrophoblasts progressively increased with advancing gestation (9) . The current results also are consistent with the decrease in placental P-450scc activity that was observed in baboons by the administration of an estrogen receptor antagonist in the second half of gestation (10) . Collectively, on the basis of these studies, we propose that the expression of the P-450scc enzyme system, and thus conversion of substrate cholesterol to progestin products catalyzed by P-450scc, are developmentally regulated in the primate placenta by estrogen.
Because the P-450scc complex consists of the cytochrome P-450scc terminal oxidase, adrenodoxin reductase flavoprotein, and adrenodoxin iron-sulfur protein (1), the changes in P-450scc activity elicited by estrogen in baboons of the present study potentially could have reflected regulation of one or more of these P-450scc enzyme components. However, we previously showed that the developmental increase in the mRNA levels for P-450scc in baboon syncytiotrophoblasts was not associated with a change in the mRNA levels for adrenodoxin (9) . In addition, the content of mitochondrial cytochrome P-450, 80 -100% of which is involved in cholesterol side-chain cleavage in the placenta (24), was significantly reduced as determined by spectral analysis in placental tissue of antiestrogen-treated baboons (10) . Therefore, on the basis of these observations plus the comparable change in mRNA levels and activity of P-450scc in animals of the present study, we suggest that the terminal oxidase is the primary component of the P-450scc system that is regulated by estrogen within syncytiotrophoblasts in the second half of baboon pregnancy. In addition to the regulatory action on the P-450scc enzyme, we recently have shown that estrogen also increased low-density lipoprotein (LDL) receptor mRNA levels and LDL uptake within syncytiotrophoblasts during baboon and human pregnancy. Thus, there was an ontogenetic increase in LDL receptor mRNA levels in (25) and LDL uptake by (14) syncytiotrophoblasts in pregnant baboons, which was blocked by inhibiting the formation (23) or action (26) of estrogen. In human syncytiotrophoblasts in culture, estradiol increased the uptake and use of LDL cholesterol for progesterone production (27) . Because the progressive increase in LDL receptor and P-450scc mRNA expression with advancing baboon pregnancy occurred specifically within the syncytiotrophoblasts (9, 25), we have proposed that there is an estrogen-dependent developmental increase in functional differentiation of syncytiotrophoblasts in the second half of primate pregnancy, which is manifested as an increase in key components of the progesterone biosynthetic pathway. Apparently, this provides the necessary substrate for the increase in placental progesterone production that is typical of primate pregnancy (6) .
Estrogen also has been shown to regulate P-450scc activity and/or expression in porcine granulosa cells (28) and the rabbit corpus luteum (29) and, along with FSH, induce the mRNA for P-450scc in vitro and in vivo in rat granulosa cells (30) . Moreover, in the laboratory rat and rabbit, species in which the corpus luteum is the principal source of progesterone during pregnancy, estrogen also regulates additional components of the progesterone biosynthetic pathway (reviewed in Refs. [31] [32] [33] . For example, high-density lipoprotein uptake (34) , de novo cholesterol biosynthesis (35) , and mitochondrial sterol carrier protein 2 content (32) were stimulated by estrogen in the corpus luteum during rat pregnancy. Cholesterol transfer within the mitochondria and/or between storage sites also was regulated by estrogen in the rabbit corpus luteum (36) . Consequently, cellular uptake and intracellular trafficking of cholesterol substrate, as well as P-450scc-catalyzed cholesterol metabolism, seem to be regulated by estrogen in both the laboratory rodent and primate. Apparently, although two completely different reproductive organs are involved in progesterone production during pregnancy in these species, estrogen has a similar key regulatory role.
Although placental P-450scc activity in fetectomized baboons was restored by androstenedione to a level similar to FIG. 6 . Representative competitive RT-PCR of P-450scc. A, Ethidium bromide stained P-450scc RT-PCR products separated on a 2% agarose gel. Total RNA (2.5 g) from placental villous tissue of an untreated term control (C) or a fetectomized baboon (Fet-X) were mixed with 2-fold serial dilutions (i.e. 500, 250, and 125 attomoles) of P-450scc-CRS. The samples were reverse transcribed and amplified for 25 cycles at 60 C annealing temperature in the presence of primers specific for P-450scc. The 370-bp P-450scc PCR target product from total RNA and 290-bp PCR product from P-450scc-CRS are indicated. B, The intensity of the amplified products in (A) were analyzed by densitometry and the log of the ratios of P-450scc-CRS and P-450scc target areas for fetectomized (å-å) and untreated control (•-•) baboons were plotted as a function of the amount of P-450scc-CRS added to each PCR reaction. The lines were constructed by linear regression analysis of the data points and the concentrations of P-450scc mRNA determined from the equivalence points (indicated by intersection of vertical lines with regression lines).
FIG. 5. P-450scc activity (pmol pregnenolone, P 5 , plus progesterone, P 4 , formed/mg mitochondrial protein⅐30 min) in mitochondria isolated from placentas obtained on day 160 of gestation from baboons that were intact and untreated (n ϭ 12), underwent fetectomy on day 100 of gestation (n ϭ 6), and underwent fetectomy on day 100 and administration of androstenedione pellets (⌬ that in intact animals late in gestation, increasing serum estrogen levels 2-fold above normal by administration of estradiol to fetectomized or androstenedione to intact animals, did not further elevate placental P-450scc. Similar observations were observed for placental LDL uptake in baboons (23) . Therefore, we suggest that placental LDL uptake and P-450scc activity are maintained at the normal levels observed in untreated controls near term by the amounts of estrogen typically present in vivo but that these aspects of the progesterone pathway cannot be enhanced above normal by further increases in the concentrations of estrogen. The latter may result from down regulation of the estrogen receptor, which is expressed in syncytiotrophoblasts of the human placenta (37, 38) , by the high levels of estrogen that are present in late gestation.
The immunocytochemical expression of placental SP 1 , the capacity to aromatize androstenedione to estradiol, the secretion of pregnancy-associated placental peptide-A (13), and the increase in P-450scc in response to estrogen shown in the present study are consistent with continued functional capacity of the placental syncytiotrophoblast after fetectomy in baboons. The syncytial trophoblast also seemed normal in the human placenta despite fetal death (39) . However, the arrest of placental growth after fetectomy, as shown in baboons of the present study, may have reflected devascularization and, consequently, impaired development of the fetal mesenchyme (39) resulting from the loss of fetal villous blood flow (40) . This suggests that factors of fetal origin other than, or in addition to, estrogen may be involved in growth and development of the fetal mesenchymal-derived vascular system; however, additional study is needed to examine this possibility.
In summary, the results of the present study show that there was a close association between the levels of estrogen and the mRNA levels for, and specific activity of, the P-450scc enzyme in the placenta during the second half of baboon pregnancy. On the basis of the present and recently published studies, we propose that estrogen regulates the biosynthesis of progesterone within the placenta by actions on the uptake of cholesterol substrate in the form of LDL and catalytic conversion of cholesterol to pregnenolone, thereafter, via the P-450scc enzyme.
FIG. 7. Placental P-450scc mRNA levels determined by competitive RT-PCR in villous tissue obtained on day 160 from baboons that were intact untreated controls (n ϭ 6), underwent fetectomy on day 100 of gestation (n ϭ 6), and underwent fetectomy on day 100 and treatment with androstenedione pellets (⌬ 4 A, n ϭ 5) between days 101-160. Values are the means (ϮSE). Values with different letter superscripts are different at P Ͻ 0.05-P Ͻ 0.01 (ANOVA, Newman-Keuls multiple comparison test).
